BioPharm International
August 01, 2013
Features
26
8
The bio-pharmaceutical business outlook in South Korea remains positive
August 01, 2013
Features
26
8
The US Supreme Court's Myriad decision satisfied both patient groups and patent holders
August 01, 2013
From the Editor
26
8
As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.
August 01, 2013
Features
26
8
The authors discuss the application of risk management in process lifecycle validation, manufacturing, and change control.
August 01, 2013
Perspectives on Outsourcing
26
8
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
August 01, 2013
Features
26
8
The author discusses HTST pasteurization and UHT sterilization.
August 01, 2013
European Beat
26
8
Nanomedicines have been authorized by European licensing agencies for more than 30 years but are still posing regulatory difficulties.
August 01, 2013
Features
26
8
Pharmaceutical companies have stepped up gene therapy development in the wake of the approval of Glybera in 2012.
August 01, 2013
Disposables Advisor
26
8
Choosing the right disposable components for your application.
August 01, 2013
Global Feature
26
8
Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.
August 01, 2013
Regulatory Beat
26
8
FDA funds research to further development of innovative generics, while working to address review and approval issues.
August 01, 2013
Boot Camp Technical Guide
26
8
Viruses in animal-derived starting materials could contaminate biopharmaceutical final product. A rigorous testing strategy and removal methods are reviewed.
August 01, 2013
Issue PDF
26
8
Click the title above to open the BioPharm International August 2013 issue in an interactive PDF format.